Barinthus Biotherapeutics plc.
BRNS$0.7008▲ 6.18% 24h
$0.7008
+$0.461(+192.22%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$28.63M
P/E ratio
—
EPS (diluted)
$-1.64
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-66.43M
Net margin
—
Gross margin
—
Dividends & financials
Barinthus Biotherapeutics plc. (BRNS) reported revenue of $0 and net income of $-66.43M, or $-1.64 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.
